Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 353

1.

Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.

Mavragani CP, Sagalovskiy I, Guo Q, Nezos A, Kapsogeorgou EK, Lu P, Liang Zhou J, Kirou KA, Seshan SV, Moutsopoulos HM, Crow MK.

Arthritis Rheumatol. 2016 Nov;68(11):2686-2696. doi: 10.1002/art.39795.

2.

Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes.

Mavragani CP, Nezos A, Sagalovskiy I, Seshan S, Kirou KA, Crow MK.

J Autoimmun. 2018 Mar;88:75-82. doi: 10.1016/j.jaut.2017.10.004. Epub 2017 Oct 23.

3.

Activation of the type I interferon pathway in primary Sjogren's syndrome.

Mavragani CP, Crow MK.

J Autoimmun. 2010 Nov;35(3):225-31. doi: 10.1016/j.jaut.2010.06.012. Epub 2010 Jul 31. Review.

PMID:
20674271
4.

Long interspersed nuclear elements (LINE-1): potential triggers of systemic autoimmune disease.

Crow MK.

Autoimmunity. 2010 Feb;43(1):7-16. doi: 10.3109/08916930903374865. Review.

PMID:
19961365
5.

TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.

Bodewes ILA, Huijser E, van Helden-Meeuwsen CG, Tas L, Huizinga R, Dalm VASH, van Hagen PM, Groot N, Kamphuis S, van Daele PLA, Versnel MA.

J Autoimmun. 2018 Jul;91:97-102. doi: 10.1016/j.jaut.2018.02.001. Epub 2018 Apr 16.

PMID:
29673738
6.

PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.

Wang Y, Ewart D, Crabtree JN, Yamamoto A, Baechler EC, Fazeli P, Peterson EJ.

Arthritis Rheumatol. 2015 Sep;67(9):2403-14. doi: 10.1002/art.39211.

7.

Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome.

Maria NI, Steenwijk EC, IJpma AS, van Helden-Meeuwsen CG, Vogelsang P, Beumer W, Brkic Z, van Daele PL, van Hagen PM, van der Spek PJ, Drexhage HA, Versnel MA.

Ann Rheum Dis. 2017 Apr;76(4):721-730. doi: 10.1136/annrheumdis-2016-209589. Epub 2016 Sep 26.

PMID:
27672125
8.

Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism.

Båve U, Nordmark G, Lövgren T, Rönnelid J, Cajander S, Eloranta ML, Alm GV, Rönnblom L.

Arthritis Rheum. 2005 Apr;52(4):1185-95.

9.

Identification of Cyclin-Dependent Kinase 1 as a Novel Regulator of Type I Interferon Signaling in Systemic Lupus Erythematosus.

Wu L, Qin Y, Xia S, Dai M, Han X, Wu Y, Zhang X, Ma J, Wang Y, Tang Y, Liu Z, Zhu W, Jallal B, Yao Y, Qu B, Shen N.

Arthritis Rheumatol. 2016 May;68(5):1222-32. doi: 10.1002/art.39543.

10.

Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.

Wang H, Li T, Chen S, Gu Y, Ye S.

Arthritis Rheumatol. 2015 Dec;67(12):3190-200. doi: 10.1002/art.39296.

11.
12.

C-reactive protein inhibits plasmacytoid dendritic cell interferon responses to autoantibody immune complexes.

Mold C, Clos TW.

Arthritis Rheum. 2013 Jul;65(7):1891-901. doi: 10.1002/art.37968.

13.

Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjögren's syndrome.

Zhao J, Kubo S, Nakayamada S, Shimajiri S, Zhang X, Yamaoka K, Tanaka Y.

Mod Rheumatol. 2016 Sep;26(5):716-24. doi: 10.3109/14397595.2015.1129694. Epub 2016 Feb 17.

PMID:
26706891
14.

Expression of type III interferons (IFNλs) and their receptor in Sjögren's syndrome.

Apostolou E, Kapsogeorgou EK, Konsta OD, Giotakis I, Saridaki MI, Andreakos E, Tzioufas AG.

Clin Exp Immunol. 2016 Dec;186(3):304-312. doi: 10.1111/cei.12865. Epub 2016 Oct 4.

15.

Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA.

Lövgren T, Eloranta ML, Kastner B, Wahren-Herlenius M, Alm GV, Rönnblom L.

Arthritis Rheum. 2006 Jun;54(6):1917-27.

16.

Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.

Gotoh K, Tanaka Y, Nishikimi A, Nakamura R, Yamada H, Maeda N, Ishikawa T, Hoshino K, Uruno T, Cao Q, Higashi S, Kawaguchi Y, Enjoji M, Takayanagi R, Kaisho T, Yoshikai Y, Fukui Y.

J Exp Med. 2010 Apr 12;207(4):721-30. doi: 10.1084/jem.20091776. Epub 2010 Mar 15.

17.

IgE Inhibits Toll-like Receptor 7- and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.

Khoryati L, Augusto JF, Shipley E, Contin-Bordes C, Douchet I, Mitrovic S, Truchetet ME, Lazaro E, Duffau P, Couzi L, Jacquemin C, Barnetche T, Vacher P, Schaeverbeke T, Blanco P, Richez C; Fédération Hospitalo-Universitaire ACRONIM.

Arthritis Rheumatol. 2016 Sep;68(9):2221-31. doi: 10.1002/art.39679.

18.

Innate immune signaling induces interleukin-7 production from salivary gland cells and accelerates the development of primary Sjögren's syndrome in a mouse model.

Jin JO, Shinohara Y, Yu Q.

PLoS One. 2013 Oct 17;8(10):e77605. doi: 10.1371/journal.pone.0077605. eCollection 2013. Erratum in: PLoS One. 2014;9(9):e108573.

19.

Biosemantics guided gene expression profiling of Sjögren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis.

Shah NR, Noll BD, Stevens CB, Brennan MT, Mougeot FB, Mougeot JC.

Arthritis Res Ther. 2017 Aug 17;19(1):192. doi: 10.1186/s13075-017-1400-3.

20.

Ductal cells of minor salivary glands in Sjögren's syndrome express LINE-1 ORF2p and APOBEC3B.

Kalogirou EM, Piperi EP, Tosios KI, Tsiambas E, Fanourakis G, Sklavounou A.

J Oral Pathol Med. 2018 Feb;47(2):179-185. doi: 10.1111/jop.12656. Epub 2017 Nov 28.

PMID:
29057505

Supplemental Content

Support Center